Paper Details

  1. Home
  2. Paper Details

[Breast cancer: new therapeutic strategies].

Author: EspieM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Metastatic breast cancer is a challenging condition. Without additional treatment after surgery, about 30% of women with no lymph node involvement and 50% of women with lymph node involvement develop metastatic disease within 10 and 5 years, respectively. Hormonal and chemotherapy treatments have shown to reduce breast cancer death by 10%. New medications like taxanes and aromatase inhibitors are showing promise in clinical trials, and may be used as additional treatments.
Paper Details　
Original Abstract of the Article :
NEED FOR NEW CHEMOTHERAPY AGENTS: Metastasic breast cancer is an excellent model for studying anticancer agents: chemotherapy or hormonotherapy or compounds modifying the organism's response. If no adjuvant treatment is given after locoregional treatment of breast cancer, metastasis will develop wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/9893697

データ提供：米国国立医学図書館（NLM）

Breast Cancer: Advancing Treatment Strategies in a Desert of Uncertainty

Metastatic breast cancer remains a significant challenge for cancer research, necessitating the development of new and effective therapeutic strategies. This review explores the [research area] of breast cancer treatment, examining the [primary objective] of exploring the need for new chemotherapy agents and evaluating the efficacy of existing treatment approaches. The authors highlight the [key findings] related to the effectiveness of adjuvant treatments, emphasizing the importance of [research area] in improving breast cancer outcomes. A particularly noteworthy observation was the [specific finding or significance] of the research.

New Frontiers in Breast Cancer Treatment: A Promise of Hope

The review underscores the importance of ongoing research in developing new chemotherapy agents and adjuvant treatments for breast cancer. The [research findings] offer hope for improved outcomes and a greater chance of survival for patients facing this challenging disease.

Navigating Breast Cancer Treatment: A Collaborative Approach

The review highlights the importance of a collaborative approach to breast cancer treatment. By [practical measures], we can optimize treatment strategies and empower patients to make informed decisions about their care.

Dr.Camel's Conclusion

The fight against breast cancer is like a long journey across a vast and unforgiving desert. The review serves as a reminder that we must continue to explore new pathways and refine existing strategies to effectively combat this disease. It underscores the importance of research, collaboration, and personalized approaches in ensuring the well-being of those affected by breast cancer.

Date :
  1. Date Completed 1999-01-21
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

9893697

DOI: Digital Object Identifier

9893697

Related Literature

Article Analysis
・Effective treatment of breast cancer
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.